Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. (25th March 2019)
- Record Type:
- Journal Article
- Title:
- Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. (25th March 2019)
- Main Title:
- Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats
- Authors:
- Tian, Huajie
Liu, Lin
Li, Zhixiong
Liu, Wei
Sun, Zhaolin
Xu, Yongbin
Wang, Shunchun
Liang, Chungeng
Hai, Yamei
Feng, Qin
Zhao, Yu
Hu, Yiyang
Peng, Jinghua - Abstract:
- Abstract: Ethnopharmacological revelvance: CGA consisting of Cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin, was demonstrated to be the effective components formula in Fuzheng Huayu (FZHY) capsule, a traditional Chinese medicine approved by China food and drug administration for treatment of liver fibrosis and to inhibit transforming growth factor-β1 (TGF-β1) signaling, previously. Aim of the study: To evaluate the effects of CGA on hepatic apoptosis in liver fibrosis induced by carbon tetrachloride (CCl4 ). Materials and methods: The hepatic injury and histology was detected by serum biomarker assay and hematoxylin-eosin staining. The hepatic collagen was illustrated by Sirius red staining and hydroxyproline (Hyp) concentration. The hepatic stellate cells (HSCs) activation and hepatic apoptosis was visualized by immunohistochemical analysis of α-smooth muscle actin (α-SMA) and terminal deoxynucleotidyl transferase-mediated dUPT nick-end labeling (TUNEL) assay respectively. The protein expression of collagen type I (Col-I), α-SMA, TGF-β1, Fas, tumor necrosis factor receptor 1 (TNF-R1), cleaved-caspase-8, cleaved-caspase-10, cleaved-caspase-9, cleaved-caspase-3, mitochondrial Bcl-2, Bcl-2 associated X protein (Bax), Bcl-2 homologous antagonist/killer (Bak), cytochrome C and cytoplasmic cytochrome C was detected by western-blot. Results: CGA or FZHY ameliorated liver histological changes, decreasing serum alanine aminotransferase, aspartateAbstract: Ethnopharmacological revelvance: CGA consisting of Cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin, was demonstrated to be the effective components formula in Fuzheng Huayu (FZHY) capsule, a traditional Chinese medicine approved by China food and drug administration for treatment of liver fibrosis and to inhibit transforming growth factor-β1 (TGF-β1) signaling, previously. Aim of the study: To evaluate the effects of CGA on hepatic apoptosis in liver fibrosis induced by carbon tetrachloride (CCl4 ). Materials and methods: The hepatic injury and histology was detected by serum biomarker assay and hematoxylin-eosin staining. The hepatic collagen was illustrated by Sirius red staining and hydroxyproline (Hyp) concentration. The hepatic stellate cells (HSCs) activation and hepatic apoptosis was visualized by immunohistochemical analysis of α-smooth muscle actin (α-SMA) and terminal deoxynucleotidyl transferase-mediated dUPT nick-end labeling (TUNEL) assay respectively. The protein expression of collagen type I (Col-I), α-SMA, TGF-β1, Fas, tumor necrosis factor receptor 1 (TNF-R1), cleaved-caspase-8, cleaved-caspase-10, cleaved-caspase-9, cleaved-caspase-3, mitochondrial Bcl-2, Bcl-2 associated X protein (Bax), Bcl-2 homologous antagonist/killer (Bak), cytochrome C and cytoplasmic cytochrome C was detected by western-blot. Results: CGA or FZHY ameliorated liver histological changes, decreasing serum alanine aminotransferase, aspartate aminotransferase, hepatic Hyp, TUNEL positive-stained area, and down-regulated the protein expression of α-SMA, TGF-β1, Col-I, Fas, TNF-R1, cleaved-caspase-8, cleaved-caspase-10, cleaved-caspase-9, and cleaved-caspase-3, mitochondrial Bax, Bak, and cytoplasmic cytochrome C, while restored the expression of mitochondrial Bcl-2 and cytochrome C. Conclusion: CGA formula ameliorates liver fibrosis induced by CCl4, which is correlated to its inhibition on hepatic apoptosis. Graphical abstract: … (more)
- Is Part Of:
- Journal of ethnopharmacology. Volume 232(2019)
- Journal:
- Journal of ethnopharmacology
- Issue:
- Volume 232(2019)
- Issue Display:
- Volume 232, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 232
- Issue:
- 2019
- Issue Sort Value:
- 2019-0232-2019-0000
- Page Start:
- 227
- Page End:
- 235
- Publication Date:
- 2019-03-25
- Subjects:
- Ethnopharmacology -- Periodicals
Pharmacognosy -- Periodicals
Herbs -- Periodicals
Herbs -- Periodicals
Pharmacognosy -- Periodicals
Pharmacognosie -- Périodiques
Herbes -- Périodiques
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03788741 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jep.2018.11.027 ↗
- Languages:
- English
- ISSNs:
- 0378-8741
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.602400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9404.xml